Lipodystrophy - in the ICD-10-CM Index

Browse the ICD-10-CM codes with references applicable to the clinical term "lipodystrophy"

• Lipodystrophy - E88.10 Lipodystrophy, unspecified

  • generalized (acquired) (congenital) - E88.12 Generalized lipodystrophy

  • HIV-associated - E88.14 HIV-associated lipodystrophy

  • injection - E88.13 Localized lipodystrophy

  • insulin - E88.13 Localized lipodystrophy

  • intestinal - K90.81 Whipple's disease

  • localized - E88.13 Localized lipodystrophy

  • mesenteric - K65.4 Sclerosing mesenteritis

  • partial (acquired) (familial) - E88.11 Partial lipodystrophy

  • progressive - E88.11 Partial lipodystrophy

  • specified type NEC - E88.19 Other lipodystrophy, not elsewhere classified

Injections: Introduction of substances into the body using a needle and syringe.

Insulin: A 51-amino acid pancreatic hormone that plays a major role in the regulation of glucose metabolism, directly by suppressing endogenous glucose production (GLYCOGENOLYSIS; GLUCONEOGENESIS) and indirectly by suppressing GLUCAGON secretion and LIPOLYSIS. Native insulin is a globular protein comprised of a zinc-coordinated hexamer. Each insulin monomer containing two chains, A (21 residues) and B (30 residues), linked by two disulfide bonds. Insulin is used as a drug to control insulin-dependent diabetes mellitus (DIABETES MELLITUS, TYPE 1).